Journal News

Huntingtin through a multiomic lens

Protein–protein interaction network leads to the synapse
Laurel Oldach
Aug. 1, 2019

Tracing the effects of a single gene’s mutation can be hard. Huntington’s disease, for example, is caused by just one mutation — but that change reverberates throughout the brain. Research published in the journal Molecular & Cellular Proteomics shows that the mutant protein that causes Huntington’s can alter the binding properties of another protein, perhaps accounting for some of the mutation’s far-flung cellular effects.

Multiomic lens

Huntington’s disease, an as-yet-untreatable neurodegenerative disorder, is caused by a mutation that affects the protein huntingtin. Huntingtin is large to begin with; in patients, a repeat region in the gene adds an expanding tract of glutamine residues to the protein, making it sticky and prone to aggregate. But how the protein change leads to profound problems in neurons is up for debate.

“Very few proteins act as a monolithic structure,” said Joel Federspiel, a postdoctoral fellow in Ileana Cristea’s lab at Princeton University. Instead, most act in coordination with other proteins. The same is probably true for huntingtin — but previous interactomics studies turned up thousands of binding partners. Which ones are important for the way the disease develops?

Recent research had shown that reducing neuronal levels of the protein HDAC4, which binds to mutated huntingtin, may reduce Huntington’s symptoms, at least in mice. Oddly, however, blocking the enzymatic activity of HDAC4, which belongs to a class of enzymes that alter histone proteins that organize DNA, did not have the same effect.

To Federspiel and Cristea, the data suggested that HDAC4 was contributing to the onset of disease through a binding interaction either with huntingtin or with other proteins. So they hopped one ripple ring away from huntingtin protein itself to study how HDAC4 changes in a brain affected by the disease.

The researchers used immunoaffinity purification followed by mass spectrometry to catalogue all of the proteins that interact with HDAC4 in the mouse brain. In a mouse model of Huntington’s, they found major changes to the HDAC4 interactome around the age at which symptoms start to appear.

“You can, in a case like this, have hundreds to thousands of proteins or transcripts that are differentially regulated,” Federspiel said. “Trying to home in on just a few of those to focus on can be challenging. However, if you have more lines of evidence, then you start to see what things are common.”

To find the significant proteins, they layered in additional data from earlier transcriptome and proteome studies. After they applied what they called a lens of multiomics, a few insights came into focus.

In the mice with huntingtin mutations that were old enough to exhibit symptoms, HDAC4 associated with many huntingtin-binding proteins — more so than in the brains of healthy mice or younger mutants.

Many of the interacting proteins were involved in the organization of synapses and vesicle transport. In the mutant mice, those proteins interact with HDAC4 much more strongly. The effect was most noticeable in cells in the striatum, a brain region that controls movement and is affected greatly in Huntington’s disease.

That’s good circumstantial evidence that, in Huntington’s-affected brains, a changing HDAC4 interactome may contribute to symptoms. Exactly how, the researchers say, remains to be determined.

Laurel Oldach

Laurel Oldach is a science writer for the ASBMB.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Part 1: ‘Aha moments’ essay contest honorable mentions
Contest

Part 1: ‘Aha moments’ essay contest honorable mentions

May 6, 2021

To celebrate our three journals going open access, we invited readers to share their moments of discovery in science. Here are two honorable mentions.

From the journals: MCP
Journal News

From the journals: MCP

May 6, 2021

Using silver nanoparticles to target cancer. Glycosylation of SARS-CoV-2. Characterizing the glycan signature in tumor tissue. Read about recent papers in the journal Molecular & Cellular Proteomics.

Ceramides’ role in liver disease
Lipid News

Ceramides’ role in liver disease

May 5, 2021

These biologically active sphingolipids have roles in apoptosis, inflammation and insulin resistance, all critical factors in the pathogenesis of chronic liver disease.

Winners of the ‘aha moments’ essay contest
Contest

Winners of the ‘aha moments’ essay contest

May 4, 2021

To celebrate our three journals going open access, we invited readers to share their moments of discovery in science. Here are the first, second and third place winners.

The 17th-century cloth merchant who discovered the vast realm of tiny microbes
News

The 17th-century cloth merchant who discovered the vast realm of tiny microbes

May 2, 2021

Although untrained in science, Antonie van Leeuwenhoek became the greatest lens-maker of his day, discovered microscopic life forms and is known today as the “father of microbiology.”

Do kids really need to be vaccinated for COVID?
News

Do kids really need to be vaccinated for COVID?

May 1, 2021

Many experts argue that Covid-19 cannot be curbed without vaccinating children. But others aren’t so sure.